PL345207A1 - Gene therapy method - Google Patents

Gene therapy method

Info

Publication number: PL345207A1
Authority: PL; Poland
Prior art keywords: gene therapy; therapy method; gene; therapy
Prior art date: 1998-06-02

Application number

PL99345207A

Other languages

English (en)

Inventor

Martin Braddock

Callum Jeffrey Campbell

Jean-Luc Schwachtgen

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-02

Filing date

1999-06-02

Publication date

2001-12-03

1998-06-02 Priority claimed from GBGB9811836.7A external-priority patent/GB9811836D0/en

1998-07-11 Priority claimed from GBGB9815035.2A external-priority patent/GB9815035D0/en

1998-09-12 Priority claimed from GBGB9819846.8A external-priority patent/GB9819846D0/en

1998-12-23 Priority claimed from GBGB9828578.6A external-priority patent/GB9828578D0/en

1999-06-02 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2001-12-03 Publication of PL345207A1 publication Critical patent/PL345207A1/xx

Links

238000001415 gene therapy Methods 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Toxicology (AREA)
Marine Sciences & Fisheries (AREA)
Biotechnology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL99345207A 1998-06-02 1999-06-02 Gene therapy method PL345207A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB9811836.7A GB9811836D0 (en)	1998-06-02	1998-06-02	Gene therapy method
GBGB9815035.2A GB9815035D0 (en)	1998-07-11	1998-07-11	Gene therapy method
GBGB9819846.8A GB9819846D0 (en)	1998-09-12	1998-09-12	Gene therapy method
GBGB9828578.6A GB9828578D0 (en)	1998-12-23	1998-12-23	Regulation
PCT/GB1999/001722 WO1999062561A2 (en)	1998-06-02	1999-06-02	Gene therapy method

Publications (1)

Publication Number	Publication Date
PL345207A1 true PL345207A1 (en)	2001-12-03

Family

ID=27451790

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99345207A PL345207A1 (en)	1998-06-02	1999-06-02	Gene therapy method

Country Status (28)

Country	Link
US (1)	US6689758B1 (de)
EP (2)	EP1083934B1 (de)
JP (1)	JP2002516676A (de)
KR (1)	KR20010043968A (de)
CN (1)	CN1311822A (de)
AP (1)	AP2000001999A0 (de)
AT (1)	ATE246518T1 (de)
AU (1)	AU770497B2 (de)
BR (1)	BR9910877A (de)
CA (1)	CA2334171A1 (de)
DE (1)	DE69910202T2 (de)
DK (1)	DK1083934T3 (de)
EA (1)	EA200001124A1 (de)
EE (1)	EE200000790A (de)
ES (1)	ES2205830T3 (de)
HR (1)	HRP20000832A2 (de)
HU (1)	HUP0103252A3 (de)
ID (1)	ID27483A (de)
IL (1)	IL139936A0 (de)
IS (1)	IS5742A (de)
NO (1)	NO20006047L (de)
NZ (1)	NZ508505A (de)
PL (1)	PL345207A1 (de)
PT (1)	PT1083934E (de)
SK (1)	SK18322000A3 (de)
TR (2)	TR200100348T2 (de)
WO (1)	WO1999062561A2 (de)
YU (1)	YU75600A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9928430D0 (en) *	1999-12-01	2000-01-26	Glaxo Group Ltd	Screening
EP1467207B1 (de) *	2002-01-10	2008-06-04	Takeda Pharmaceutical Company Limited	Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
AU2003302337A1 (en) *	2002-12-31	2004-07-29	The Johns Hopkins University	Wound healing method and kits
EP1671655A4 (de) *	2003-08-29	2009-08-12	Anges Mg Inc	Gentherapie für hauterkrankungen mit nadelfreier spritze
DE10342071B4 (de) *	2003-09-10	2006-01-19	Fleischmann, Wilhelm, Dr.med.	Vorrichtung und Verfahren zur Applikation von Wïrkstoffen an eine Wundoberfläche
KR100647490B1 (ko)	2004-10-04	2006-11-23	사회복지법인 삼성생명공익재단	저산소 조건 및 다른 스트레스에 특이적으로 반응할 수있는 키메라 인핸서 요소를 포함하는 벡터, 상기 벡터를포함하는 약제학적 조성물 및 상기 조성물을 이용하는 방법
HRP20150759T1 (hr)	2007-05-11	2015-08-14	Adynxx, Inc.	Ekspresija gena i bolovi
FR2920158B1 (fr) *	2007-08-24	2010-03-12	Centre Nat Rech Scient	Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
FR2924128A1 (fr) *	2007-11-26	2009-05-29	Galderma Res & Dev	Modulateurs de egr1 dans le traitement de l'alopecie
WO2011008904A1 (en)	2009-07-17	2011-01-20	Tabor Aaron T	Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
CN102552938A (zh) *	2012-03-22	2012-07-11	南京大学	Egr-1拮抗剂在制备治疗Ⅱ型糖尿病的药物中的用途
CN104487096B (zh)	2012-05-10	2020-09-15	埃迪恩克斯股份有限公司	用于活性成分递送的配制物
CA2957250A1 (en)	2014-08-15	2016-02-18	Adynxx, Inc.	Oligonucleotide decoys for the treatment of pain
KR101721228B1 (ko) *	2015-04-03	2017-03-30	사회복지법인 삼성생명공익재단	지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
CN104857529A (zh) *	2015-05-20	2015-08-26	山西大学	Egr-1基因在制备抗膀胱癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5763209A (en)	1988-09-26	1998-06-09	Arch Development Corporation	Methods and materials relating to the functional domains of DNA binding proteins
US5206152A (en) *	1988-04-08	1993-04-27	Arch Development Corporation	Cloning and expression of early growth regulatory protein genes
AUPN855496A0 (en)	1996-03-07	1996-04-04	Unisearch Limited	Prevention of proliferation of vascular cells

1999
- 1999-06-02 YU YU75600A patent/YU75600A/sh unknown
- 1999-06-02 TR TR2001/00348T patent/TR200100348T2/xx unknown
- 1999-06-02 EP EP99925174A patent/EP1083934B1/de not_active Expired - Lifetime
- 1999-06-02 CA CA002334171A patent/CA2334171A1/en not_active Abandoned
- 1999-06-02 AU AU41560/99A patent/AU770497B2/en not_active Expired - Fee Related
- 1999-06-02 DE DE69910202T patent/DE69910202T2/de not_active Expired - Fee Related
- 1999-06-02 BR BR9910877-1A patent/BR9910877A/pt not_active IP Right Cessation
- 1999-06-02 AP APAP/P/2000/001999A patent/AP2000001999A0/en unknown
- 1999-06-02 WO PCT/GB1999/001722 patent/WO1999062561A2/en not_active Ceased
- 1999-06-02 PT PT99925174T patent/PT1083934E/pt unknown
- 1999-06-02 IL IL13993699A patent/IL139936A0/xx unknown
- 1999-06-02 KR KR1020007013584A patent/KR20010043968A/ko not_active Withdrawn
- 1999-06-02 EE EEP200000790A patent/EE200000790A/xx unknown
- 1999-06-02 US US09/701,749 patent/US6689758B1/en not_active Expired - Fee Related
- 1999-06-02 EP EP02020179A patent/EP1281763A3/de not_active Withdrawn
- 1999-06-02 AT AT99925174T patent/ATE246518T1/de not_active IP Right Cessation
- 1999-06-02 SK SK1832-2000A patent/SK18322000A3/sk unknown
- 1999-06-02 EA EA200001124A patent/EA200001124A1/ru unknown
- 1999-06-02 DK DK99925174T patent/DK1083934T3/da active
- 1999-06-02 PL PL99345207A patent/PL345207A1/xx not_active Application Discontinuation
- 1999-06-02 TR TR2001/02985T patent/TR200102985T2/xx unknown
- 1999-06-02 HR HR20000832A patent/HRP20000832A2/hr not_active Application Discontinuation
- 1999-06-02 NZ NZ508505A patent/NZ508505A/xx unknown
- 1999-06-02 HU HU0103252A patent/HUP0103252A3/hu unknown
- 1999-06-02 CN CN99809287A patent/CN1311822A/zh active Pending
- 1999-06-02 ID IDW20002711A patent/ID27483A/id unknown
- 1999-06-02 ES ES99925174T patent/ES2205830T3/es not_active Expired - Lifetime
- 1999-06-02 JP JP2000551815A patent/JP2002516676A/ja active Pending
2000
- 2000-11-28 IS IS5742A patent/IS5742A/is unknown
- 2000-11-29 NO NO20006047A patent/NO20006047L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2334171A1 (en)	1999-12-09
ES2205830T3 (es)	2004-05-01
HUP0103252A2 (hu)	2001-12-28
EP1083934A2 (de)	2001-03-21
AU770497B2 (en)	2004-02-26
ID27483A (id)	2001-04-12
PT1083934E (pt)	2003-12-31
IL139936A0 (en)	2002-02-10
EP1281763A3 (de)	2003-07-09
BR9910877A (pt)	2002-01-22
EP1083934B1 (de)	2003-08-06
WO1999062561A3 (en)	2000-08-03
JP2002516676A (ja)	2002-06-11
WO1999062561A2 (en)	1999-12-09
NZ508505A (en)	2003-04-29
EA200001124A1 (ru)	2001-08-27
CN1311822A (zh)	2001-09-05
NO20006047L (no)	2001-02-01
TR200102985T2 (tr)	2002-06-21
HRP20000832A2 (en)	2001-04-30
EP1281763A2 (de)	2003-02-05
YU75600A (sh)	2004-03-12
NO20006047D0 (no)	2000-11-29
DK1083934T3 (da)	2003-12-01
DE69910202D1 (de)	2003-09-11
HK1034465A1 (en)	2001-10-26
AU4156099A (en)	1999-12-20
KR20010043968A (ko)	2001-05-25
ATE246518T1 (de)	2003-08-15
IS5742A (is)	2000-11-28
DE69910202T2 (de)	2004-06-17
EE200000790A (et)	2002-04-15
HUP0103252A3 (en)	2003-09-29
US6689758B1 (en)	2004-02-10
AP2000001999A0 (en)	2000-12-31
SK18322000A3 (sk)	2001-11-06
TR200100348T2 (tr)	2001-07-23

Legal Events

Date	Code	Title	Description
2007-12-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
GB9622500D0 (en)	1997-01-08	Therapeutic gene
EP1077996A4 (de)	2003-05-02	Menschliches edg3sb-gen
HUP0104046A3 (en)	2003-09-29	Adenovirus-mediated gene therapy
HUP0103252A3 (en)	2003-09-29	Gene therapy method
GB9816556D0 (en)	1998-09-30	Therapy
GB9719161D0 (en)	1997-11-12	New therapeutic method
GB9714841D0 (en)	1997-09-17	Treatment method
GB9814055D0 (en)	1998-08-26	Method
GB9924981D0 (en)	1999-12-22	Gene therapy
GB9900009D0 (en)	1999-02-24	Gene therapy
GB9815035D0 (en)	1998-09-09	Gene therapy method
GB9814989D0 (en)	1998-09-09	Gene therapy method
GB9819826D0 (en)	1998-11-04	Gene therapy method
GB9811836D0 (en)	1998-07-29	Gene therapy method
GB9819846D0 (en)	1998-11-04	Gene therapy method
GB9706469D0 (en)	1997-05-14	Genetic method
GB0406539D0 (en)	2004-04-28	Gene therapy
GB9809780D0 (en)	1998-07-08	Method
GB9719176D0 (en)	1997-11-12	New therapeutic method
GB9719189D0 (en)	1997-11-12	New therapeutic method
GB9804285D0 (en)	1998-04-22	Therapeutic method
GB9800683D0 (en)	1998-03-11	Therapeutic method
GB9806039D0 (en)	1998-05-20	Therapy
GB9826753D0 (en)	1999-01-27	Genetic method
GB9818001D0 (en)	1998-10-14	Genetic method